NCT04389034

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

Retrospective Data Collection Based on Patient Records and Questionaire Based Data of Therapy Results of Allergen-specific Immunotherapy With Pollinex Quattro With Tree and/or Gras Pollen Extracts and Their Mixtures

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 113 (actual)
• Sponsor: Allergy Therapeutics · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Primary goal of this non-interventional study is to evaluate the change in level of allergen-specific IgE (EAST class) after allergen-specific immunotherapy with Pollinex Quattro with tree and/or grass pollen extracts and their mixtures under medial routine at adults with tree- and/or grass-medicated pollinosis.

Detailed description

In this non-interventional study, the change in level of allergen-specific IgE before and after 3 or more years of allergen-specific immunotherapy with Pollinex Quattro in a patient population with tree and/or grass pollen induced pollinosis and/or asthma will be analyzed. In addition, the change in medication usage, asthma status for asthmatic patients after 3, 4 or 5 years of allergen specific immunotherapy will be evaluated. Furthermore, patients will be asked for their change in quality of life after therapy end.

Conditions

• Rhinitis, Allergic
• Respiratory Tract Infections
• Allergy
• Allergic Asthma
• Allergic Conjunctivitis

Interventions

Type	Name	Description
DRUG	Pollinex Quattro with tree- and grass pollen extracts and their mixtures	retrospective analysis of patient records of allergen-specific immunotherapy

Timeline

• Start date: 2020-04-22
• Primary completion: 2020-10-05
• Completion: 2020-10-05
• First posted: 2020-05-15
• Last updated: 2021-02-08

Locations

1 site across 1 country: Germany